We are testing a new treatment called I-DXd for patients with recurrent or metastatic solid tumors. The study aims to see how well it works and how safe it is for participants.
Health conditions and diseases that the clinical trial is designed to study and treat.
Recurrent or Metastatic Solid Tumors refer to cancers that have returned after treatment or spread from their original site to other parts of the body. This category includes various types of cancers such as endometrial cancer, head and neck squamous cell carcinoma, pancreatic cancer, colorectal cancer, hepatocellular carcinoma, and more.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.
